News

Dark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance

A new liver cancer trial explores a “two-in-one" treatment approach

Providence Cancer Institute secures three significant grants

Expanded day surgery unit brings faster access to care in Clackamas County

Q&A: Meet one of the investigational drug pharmacists at Providence

New T-cell therapy for KRAS G12D cancers

Precision treatment for prostate cancer with MRI-guided radiation therapy

When standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer

Hope comes in a clinical trial: Brad’s remarkable story